ClinicalTrials.Veeva

Menu

A Telephone-delievered Intervention to Reduce Methamphetamine Use (R2C-M)

T

Turning Point

Status

Completed

Conditions

Methamphetamine Use Disorder

Treatments

Other: Self-help booklet
Behavioral: R2C-M

Study type

Interventional

Funder types

Other

Identifiers

NCT04713124
E20/011/61428

Details and patient eligibility

About

Australia has one of the highest rates of methamphetamine use in the world; however, uptake of face-to-face psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame) and structural (e.g. service availability, geography) barriers to accessing care. Addressing these barriers through the provision of alternative treatment delivery models is imperative, particularly as effective and earlier intervention is likely to reduce the need for more costly and intensive treatment resulting from escalating methamphetamine use.

In this project, the investigators will conduct the first double-blind, parallel-group, randomised controlled trial (RCT) examining the effectiveness of the structured telephone-delivered intervention, Ready2Change (R2C), among participants with methamphetamine use problems (R2C-M). Cost effectiveness of R2C-M will also be investigated. Factors influencing program implementation will be evaluated to inform the scalability of this intervention for practice nationally, and for replication internationally.

Enrollment

204 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18+ years
  • Mild or moderate methamphetamine use disorder (DSM-5 diagnosis confirmed at baseline assessment using the Structured Clinical Interview for DSM-5 Disorders - Research Version, SCID-5-RV)
  • Used methamphetamine on at least two occasions in the past month
  • Seeking to reduce methamphetamine use
  • Able to provide informed consent, and comply with the requirements of the treatment protocol
  • Willing to provide the contact details of their general practitioner or other treating physician, for follow-up
  • English as a first language or fluent
  • Educated to high school level (literacy)
  • Regular access to a telephone
  • Postal/email address to receive intervention materials

Exclusion criteria

  • Currently receiving treatment for substance use disorder (e.g. medically supervised detoxification, residential rehabilitation, drug counselling, pharmacotherapy - this criterion applies only at trial enrolment, and does not preclude the participant from entering treatment/receiving usual care during the trial)
  • Requiring acute care for severe substance use disorder (DSM-5 diagnosis confirmed at baseline using the SCID-5-RV, with oversight from the Principal Investigator or Study Clinician)
  • Requiring acute care for active suicidality or unstable psychiatric condition
  • A diagnosed primary psychotic disorder (schizophrenia, schizoaffective disorder, bipolar disorder)
  • Pregnancy
  • Hearing impairment that would prohibit participation in telephone intervention / follow-up assessments

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

204 participants in 2 patient groups

R2C-M intervention
Experimental group
Description:
R2C-M telephone intervention - Six approximately weekly sessions of R2C-M telephone-delivered intervention (50 minutes in duration), delivered by the same R2C-M Counsellor each session (a qualified clinical psychologist trained in the R2C protocol by the developer, Dr Kate Hall). Call duration will be recorded. Sessions will be digitally recorded, and an independent researcher will randomly select and rate fidelity of intervention sessions for 20% of participants. R2C-M workbooks - Two workbooks to facilitate counsellor-delivered exercises within sessions, and between-session practice, will be mailed/emailed to participants. Self-help booklet - (as in control group) R2C-M participants will also receive a booklet of information and self-help strategies for methamphetamine use problems.
Treatment:
Behavioral: R2C-M
Other: Self-help booklet
Control
Active Comparator group
Description:
Self-help booklet - Control participants will receive (by mail/email) a booklet of information and self-help strategies for methamphetamine use problems. Telephone check-ins + information on further support - (to control for frequency of contact across treatment arms) Participants in this group will receive 6 telephone calls from the research team (lasting maximum 5 minutes, call duration will be recorded). During these calls, participants will be asked about their use of the booklet. Whenever required, the researcher will provide participants with information on further support (e.g. DirectLine or other state/territory AOD helpline for advice or referral).
Treatment:
Other: Self-help booklet

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jasmin Grigg

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems